The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 8 Aug 2006
doi: 10.1242/jcs.03077
Research Article
Activation of Tie2 by angiopoietin-1 and angiopoietin-2 results in their release and receptor internalization
Elena Bogdanovic,
Vicky P.K.H. Nguyen,
and
Daniel J. Dumont*
* Author for correspondence (e-mail: dan.dumont{at}swri.ca)
The receptor tyrosine kinase Tie2 is highly expressed in endothelial cells and is crucial for angiogenesis and vascular maintenance. The ligands for Tie2 are the angiopoietins, of which angiopoietin-1 and angiopoietin-2 have been the most studied. Angiopoietin-1 has been characterized as the primary activating ligand for Tie2 whereas the role of angiopoietin-2 remains controversial; activating Tie2 in some studies and inhibiting Tie2 in others. Our studies were aimed at understanding the regulation of Tie2 in endothelial cells by angiopoietin-1 and angiopoietin-2 and revealed that both ligands activated Tie2 in a concentration-dependent manner. Angiopoietin-2 was considerably weaker at activating Tie2 compared with angiopoietin-1 suggesting that angiopoietin-2 may be a partial agonist. Activation of Tie2 by these ligands resulted in differential turnover of the receptor where binding of angiopoietin-1, and to a lesser extent angiopoietin-2, induced rapid internalization and degradation of Tie2. Furthermore, our binding studies demonstrate that both ligands are differentially released from the endothelial cell surface after receptor activation and accumulate in the surrounding medium. Altogether, these data begin our understanding of the regulation of Tie2 and the activity of the angiopoietins after engaging the endothelial cell surface.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
B. L. Falcon, H. Hashizume, P. Koumoutsakos, J. Chou, J. V. Bready, A. Coxon, J. D. Oliner, and D. M. McDonald
Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
Am. J. Pathol.,
November 1, 2009;
175(5):
2159 - 2170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. van Meurs, N. F. Kurniati, F. M. Wulfert, S. A. Asgeirsdottir, I. A. de Graaf, S. C. Satchell, P. W. Mathieson, R. M. Jongman, P. Kumpers, J. G. Zijlstra, et al.
Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function
Am J Physiol Renal Physiol,
August 1, 2009;
297(2):
F272 - F281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Woolf, L. Gnudi, and D. A. Long
Roles of Angiopoietins in Kidney Development and Disease
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
239 - 244.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Cai, O. Kehoe, G. M. Smith, P. Hykin, and M. E. Boulton
The Angiopoietin/Tie-2 System Regulates Pericyte Survival and Recruitment in Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci.,
May 1, 2008;
49(5):
2163 - 2171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mukhopadhyay, M. Shah, F. Xu, K. Patel, R. M. Tuder, and P. B. Sehgal
Cytoplasmic provenance of STAT3 and PY-STAT3 in the endolysosomal compartments in pulmonary arterial endothelial and smooth muscle cells: implications in pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol,
March 1, 2008;
294(3):
L449 - L468.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Maliba, A. Brkovic, P.-E. Neagoe, L. R. Villeneuve, and M. G. Sirois
Angiopoietin-mediated endothelial P-selectin translocation: cell signaling mechanisms
J. Leukoc. Biol.,
February 1, 2008;
83(2):
352 - 360.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M.L. Ebos, C. R. Lee, E. Bogdanovic, J. Alami, P. Van Slyke, G. Francia, P. Xu, A. J. Mutsaers, D. J. Dumont, and R. S. Kerbel
Vascular Endothelial Growth Factor Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth
Cancer Res.,
January 15, 2008;
68(2):
521 - 529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Findley, M. J. Cudmore, A. Ahmed, and C. D. Kontos
VEGF Induces Tie2 Shedding via a Phosphoinositide 3-Kinase/Akt Dependent Pathway to Modulate Tie2 Signaling
Arterioscler Thromb Vasc Biol,
December 1, 2007;
27(12):
2619 - 2626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Tressel, R.-P. Huang, N. Tomsen, and H. Jo
Laminar Shear Inhibits Tubule Formation and Migration of Endothelial Cells by an Angiopoietin-2-Dependent Mechanism
Arterioscler Thromb Vasc Biol,
October 1, 2007;
27(10):
2150 - 2156.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Rigau, M. Morin, M.-C. Rousset, F. de Bock, A. Lebrun, P. Coubes, M.-C. Picot, M. Baldy-Moulinier, J. Bockaert, A. Crespel, et al.
Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy
Brain,
July 1, 2007;
130(7):
1942 - 1956.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. B. Sehgal and S. Mukhopadhyay
Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs?
Am J Physiol Heart Circ Physiol,
July 1, 2007;
293(1):
H77 - H85.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Murdoch, S. Tazzyman, S. Webster, and C. E. Lewis
Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-2
J. Immunol.,
June 1, 2007;
178(11):
7405 - 7411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Vart, L. L. Nikitenko, D. Lagos, M. W.B. Trotter, M. Cannon, D. Bourboulia, F. Gratrix, Y. Takeuchi, and C. Boshoff
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 and G-Protein-Coupled Receptor Regulate Angiopoietin-2 Expression in Lymphatic Endothelial Cells
Cancer Res.,
May 1, 2007;
67(9):
4042 - 4051.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2006
